Gestion des effets secondaires de la suppression androgénique

25 novembre 2008

Auteurs : T. Lebret, A. Méjean
Référence : Prog Urol, 2008, 18, S338, suppl. S7
   
 
 

 

 
Le texte complet de cet article est disponible en PDF.
Cliquer ici pour le visualiser

   

 

 
 
 

Références

 

Schow D.A., Renfer L.G., Rozanski T.A., Thompson I.M. Prevalence of hot flushes during and after neoadjuvant hormonal therapy for localized prostate cancer South Med J 1998 ;  91 : 855-857 [cross-ref]
 
Charig C.R., Rundle J.S. Flushing. Long-term side effect of orchiectomy in treatment of prostatic carcinoma Urology 1989 ;  33 : 175-178 [cross-ref]
 
Karling P., Hammar M., Varenhorst E. Prevalence and duration of hot flushes after surgical or medical castration in men with prostatic carcinoma J Urol 1994 ;  152 : 1170-1173 [cross-ref]
 
Smith J.A. Management of hot flushes due to endocrine therapy for prostate carcinoma Oncology 1996 ;  10 : 1319-1322 [cross-ref]
 
Smith J.A. A prospective comparaison of treatments for symptomatic hot flashes following endocrine treatment for carcinoma of the prostate J. Urol 1994 ;  152 : 132-134 [cross-ref]
 
Frödin T., Alund G., Varenhorst E. Measurement of skin bloodflow and water evaporation as a means of objectively assessing hot flushes after orchidectomy in patients with prostatic cancer Prostate 1985 ;  7 : 203-208
 
Miller J.I., Ahmann F.R. Treatment of castration-induced menopausal symptoms with low dose diethylstilbestrol in men with advanced prostate cancer Urology 1992 ;  40 : 499-502 [cross-ref]
 
Loprinzi C.L., Pisansky T.M., Fonseca R., et al. Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors J Clin Oncol 1998 ;  16 : 2377-2381 [cross-ref]
 
Quella S.K., Loprinzi C.L., Sloan J., et al. Pilot evaluation of venlafaxine for the treatment of hot flashes in men undergoing androgen ablation therapy for prostate cancer J Urol 1999 ;  162 : 98-102 [cross-ref]
 
Holzbeierlein J.M. Managing complications of androgen deprivation therapy for prostate cancer Urol Clin North Am 2006 ;  33 : 181-190 [inter-ref]
 
Parra R.O., Gregory J.G. Treatment of post-orchiectomy hot flashes with transdermal administration of clonidine J Urol 1990 ;  143 : 753-754 [cross-ref]
 
Langenstroer P., Kramer B., Cutting B., et al. Parenteral medroxyprogesterone for the management of luteinizing hormone releasing hormone induced hot flashes in men with advanced prostate cancer J Urol 2005 ;  174 : 642-645 [cross-ref]
 
Hammar M., Grisk J., Grimes O., et al. Accupuncture treatment of vasomotor symptom sin men with prostatic carcinoma:a pilot study J Urol 1999 ;  161 : 853-856 [cross-ref]
 
Barton D.L., Loprinzi C.L., Quella S.K., et al. Prospective evaluation of vitamin E for hot flashes in breast cancer survivors J Clin Oncol 1998 ;  16 : 495-500 [cross-ref]
 
Braga-Basaria M., Dobs A.S., Muller D.C., et al. Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy J Clin Oncol 2006 ;  24 : 3979-3983 [cross-ref]
 
Tayek J.A., Heber D., Byerley L.O., Steiner B., Rajfer J., Swerdloff R.S. Nutritional and metabolic effects of gonadotropinreleasing hormone agonist treatment for prostate cancer Metabolism 1990 ;  39 : 1314-1319 [cross-ref]
 
Higano C.S., Ellis W., Russell K., Lange P.H. Intermittent androgen suppression with leuprolide and flutamide for prostate cancer: a pilot study Urology 1996 ;  48 : 800-804 [inter-ref]
 
Segal R.J., Reid R.D., Courneya K.S., et al. Resistance exercise in men receiving androgen deprivation therapy for prostate cancer J Clin Oncol 2003 ;  21 : 1653-1659 [cross-ref]
 
Strum S.B., McDermed J.E., Scholz M.C., Johnson H., Tisman G. Anaemia associated with androgen deprivation in patients with prostate cancer receiving combined hormone blockade Br J Urol 1997 ;  79 : 933-941
 
Green H.J., Pakenham K.I., Headley B.C., et al. Altered cognitive function in men treated for prostate cancer with luteinizing hormone-releasing hormone analogues and cyproterone acetate:a randomized controlled trial BJU Int 2002 ;  90 : 427-432 [cross-ref]
 
Salminen E.K., Portin R.I., Koskinen A., Helenius H., Nurmi M. Associations between serum testosterone fall and cognitive function in prostate cancer patients Clin Cancer Res 2004 ;  10 : 7575-7582 [cross-ref]
 
   
 
 
   

 

© 2008  Elsevier Masson SAS. Tous droits réservés.